| P2093 | author name string | Vindeløv L | |
| P2860 | cites work | The graft-versus-leukemia effects of allogeneic cell therapy | Q33540284 |
| | A history of haemopoietic cell transplantation | Q33610841 |
| | Intensive treatment for multiple myeloma: where do we stand? | Q33709697 |
| | Mixed chimerism: preclinical studies and clinical applications | Q33721521 |
| | Successful treatment of metastatic renal cell carcinoma with a nonmyeloablative allogeneic peripheral-blood progenitor-cell transplant: evidence for a graft-versus-tumor effect. | Q33880215 |
| | Hematopoietic stem cell transplants after reduced intensity conditioning regimen (RI-HSCT): report of a workshop of the European group for Blood and Marrow Transplantation (EBMT). | Q33917021 |
| | Mixed chimerism and tolerance without whole body irradiation in a large animal model | Q37202108 |
| | The future of allogeneic hematopoietic stem cell transplantation: minimizing pain, maximizing gain | Q37202502 |
| | Antileukemic Effect of Graft-versus-Host Disease in Human Recipients of Allogeneic-Marrow Grafts | Q39244446 |
| | Remission of relapsed leukaemia during a graft-versus-host reaction. A "graft-versus-leukaemia reaction" in man? | Q39503281 |
| | Graft-versus-leukaemia reactivity induced by alloimmunisation without augmentation of graft-versus-host reactivity | Q41110821 |
| | The immunopathophysiology of acute graft-versus-host-disease | Q41185700 |
| | Human minor histocompatibility antigens: new concepts for marrow transplantation and adoptive immunotherapy | Q41561713 |
| | Allogeneic bone marrow transplant is not better than autologous transplant for patients with relapsed Hodgkin's disease. European Group for Blood and Bone Marrow Transplantation. | Q51030809 |
| | Long-term follow-up of patients who achieved complete remission after donor leukocyte infusions. | Q54437663 |
| | Allogeneic bone marrow transplantation with co-stimulatory blockade induces macrochimerism and tolerance without cytoreductive host treatment | Q56906119 |
| | Transplantation of anergic histoincompatible bone marrow allografts | Q56906962 |
| | The new immunology--the end of immunosuppressive drug therapy? | Q56906972 |
| | Adoptive immunotherapy for relapse of chronic myeloid leukemia after allogeneic bone marrow transplant: equal efficacy of lymphocytes from sibling and matched unrelated donors | Q58455828 |
| | Allogeneic bone marrow transplantation in aggressive non-Hodgkin's lymphoma (excluding Burkitt and lymphoblastic lymphoma): a series of 73 patients from the SFGM database | Q61053545 |
| | Induction of remission after donor leucocyte infusion for the treatment of relapsed chronic idiopathic myelofibrosis following allogeneic transplantation: evidence for a 'graft vs. myelofibrosis' effect | Q64019035 |
| | Regression of Metastatic Renal-Cell Carcinoma after Nonmyeloablative Allogeneic Peripheral-Blood Stem-Cell Transplantation | Q64038880 |
| | Graft-versus-myeloma effect in two cases | Q71060552 |
| | Graft-versus-myeloma effect | Q71264400 |
| | Adoptive immunotherapy for relapsed multiple myeloma after allogeneic bone marrow transplantation (BMT): evidence for a graft-versus-myeloma effect | Q73014175 |
| | Donor leukocyte infusions in 140 patients with relapsed malignancy after allogeneic bone marrow transplantation | Q73117300 |
| | Bone marrow transplantation after failure of autologous transplant for non-Hodgkin's lymphoma | Q73261933 |
| | Allogeneic hematopoietic transplantation for mantle-cell lymphoma: molecular remissions and evidence of graft-versus-malignancy | Q73345492 |
| | Allogeneic blood or marrow transplantation for chronic lymphocytic leukaemia: timing of transplantation and potential effect of fludarabine on acute graft-versus-host disease | Q73367198 |
| | Management of lymphoma recurrence after allogeneic transplantation: the relevance of graft-versus-lymphoma effect | Q73383043 |
| | Mini-allografts: ongoing trials in humans | Q73562857 |
| | Potential allogeneic graft-versus-tumor effect in a patient with ovarian cancer | Q73586584 |
| | Outcome of allogeneic stem cell transplantation for B cell chronic lymphocytic leukemia | Q73616922 |
| | Allogeneic peripheral blood stem cell transplantation using a fludarabine-based low intensity conditioning regimen for malignant lymphoma | Q73828898 |
| | Bone marrow transplantation from HLA-identical siblings as first-line treatment in patients with myelodysplastic syndromes: early transplantation is associated with improved outcome. Chronic Leukemia Working Party of the European Group for Blood and | Q74266609 |
| | Allogeneic peripheral-blood progenitor-cell transplantation for poor-risk patients with metastatic breast cancer | Q74329718 |
| | Transplant-lite: induction of graft-versus-malignancy using fludarabine-based nonablative chemotherapy and allogeneic blood progenitor-cell transplantation as treatment for lymphoid malignancies | Q77093417 |
| | Induction of a graft-versus-leukemia reaction by cyclosporin A withdrawal as immunotherapy for leukemia relapsing after allogeneic bone marrow transplantation | Q77409049 |
| | Graft-versus-myeloma | Q77597294 |
| | Evidence of cytogenetic and molecular remission by allogeneic cells after immunosuppressive therapy alone | Q77597730 |
| | Mixed lymphohaemopoietic chimerism and graft-versus-lymphoma effects after non-myeloablative therapy and HLA-mismatched bone-marrow transplantation | Q77810550 |
| | Mixed hematopoietic chimerism after marrow allografts. Transplantation in the ambulatory care setting | Q77891876 |
| P433 | issue | 2 | |
| P921 | main subject | bone marrow | Q546523 |
| P304 | page(s) | 73-82 | |
| P577 | publication date | 2001-02-01 | |
| P1433 | published in | European Journal of Haematology | Q15765799 |
| P1476 | title | Allogeneic bone marrow transplantation with reduced conditioning (RC-BMT). | |
| P478 | volume | 66 | |